Lisata Therapeutics: Reduction in Workforce Includes Elimination of Executive Vice Pres of R&D, Chief Medical Officer Position >LSTA

Dow Jones2026/08/04 11:05

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Oportun Financial files initial beneficial ownership statement for CFO William H. Franklin

Reuters•2026/09/14 22:06

Exchange Traded Funds Top 10 Volume Leaders

Dow Jones•2026/09/14 21:38

Dogecoin price rises 3%—but $0.09 still stands in the way

AMBCrypto•2026/09/14 21:33

Bitcoin production rebounds in August for BitFuFu, edges higher at CleanSpark as Canaan slips

The Block•2026/09/14 21:33